Trial Profile
Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Copper (Primary) ; Etonogestrel (Primary) ; Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- 12 Sep 2017 ParaGard T 380A Intrauterine Copper Contraceptive will also be studied, treatment arm is added for the device.
- 12 Sep 2017 Planned number of patients changed from 90 to 120.
- 10 Jun 2017 Biomarkers information updated